Welcome to our dedicated page for Ingredion news (Ticker: INGR), a resource for investors and traders seeking the latest updates and insights on Ingredion stock.
Ingredion Incorporated reports developments tied to its global ingredient solutions business for food, beverage, animal nutrition, brewing, industrial and pharmaceutical applications. Company news commonly covers quarterly and full-year earnings, operating income drivers, guidance, dividends and share repurchase activity, along with demand, volume and cost trends in its ingredient businesses.
Updates also address Ingredion's plant-based materials portfolio, including starches, sweeteners, texturizers, plant-based proteins and functional excipients. Other recurring themes include responsible sourcing and regenerative agriculture initiatives, distribution arrangements for Ingredion Pharma Solutions, board and executive governance changes, and restructuring or facility actions that affect manufacturing operations.
Ingredion (NYSE: INGR) appointed Kenneth Escoe to its board of directors, effective July 1. Escoe is executive vice president of Specialty Products at Illinois Tool Works and brings experience in capital-intensive businesses, global operations, food and beverage packaging, and M&A-driven growth.
Ingredion (NYSE: INGR) announced a recommended all-cash acquisition of Tate & Lyle, valuing the target at approximately £3.7B ($5.0B). Tate & Lyle shareholders will receive 595p per share, a ~59% premium, plus specified dividends. Ingredion targets $130M run-rate cost synergies by 2030, with about $175M one-time costs, expects the deal to be adjusted EPS accretive in the first year post-close, and sees completion in H2 2027, funded by cash, new debt and a committed bridge, at around 3.0x net debt/EBITDA at closing.
Ingredion (NYSE: INGR) announced the acquisition of Benicaros, a patented prebiotic fiber made from upcycled carrot pomace and clinically shown to support immune health.
Benicaros delivers benefits at very low dosage, is water-soluble, clean-label, and suitable for foods, beverages, and supplements. The asset deal includes all intellectual property, trademarks, human clinical trials, and manufacturing know-how.
Ingredion (NYSE: INGR) announced a strategic joint venture with Sanstar Limited, including a 9% equity investment in India’s leading corn-based specialty products manufacturer. The partnership targets high-growth pharma and food ingredient markets in India.
The companies will build a greenfield facility to produce specialty pharmaceutical and other high-value ingredient products, creating a vertically integrated, science-led platform serving food, beverage, pharmaceutical, home and beauty customers and supporting export opportunities from India.
Ingredion (NYSE: INGR) reported major progress in its 2025 Sustainability Report, achieving 96.3% sustainable sourcing of tier 1 priority crops, up from 25% five years ago. These crops include corn, tapioca, potato, stevia and pulses.
The company follows verified industry standards covering environmental and social thresholds across the crop lifecycle. Other 2025 highlights include diverting 95% of operational waste from landfills, reaching zero waste to landfill at 16 plants, launching a stand-alone Human Rights Policy, growing an upcycled ingredients portfolio to 50+ certified products, and starting an end-to-end sustainable innovation program.
Ingredion (NYSE: INGR) announced that its board declared a quarterly dividend of $0.82 per share on its common stock. The dividend is payable on July 21, 2026, to shareholders of record as of the close of business on July 1, 2026.
Ingredion (NYSE: INGR) reported 1Q26 results: reported diluted EPS $2.22 and adjusted EPS $2.34, versus $3.00 and $2.97 in 1Q25. First-quarter net sales were $1,792 million (down 1%) and reported operating income was $203 million (down 26%); adjusted operating income was $212 million (down 22%).
The company cited operational challenges at its Argo facility as a primary driver of weaker U.S./CAN results and updated full-year 2026 guidance: reported EPS $9.60–$10.30 and adjusted EPS $10.45–$11.15, with full-year net sales flat to up low single-digits.
Ingredion (NYSE: INGR) will release first quarter 2026 financial results for the period ended March 31, 2026 before the market opens on Tuesday, May 5, 2026. Management will host a conference call on May 5 at 8:00 a.m. CT to discuss results, with a live webcast and post-event replay available on the company website.
Investors are encouraged to join the webcast about 10 minutes early; a slide presentation will accompany the call.
CIBO Technologies and Ingredion (NYSE:INGR) announced a three-year strategic partnership to scale regenerative agriculture across supply chains, expanding farmer enrollment across Iowa and Illinois and using CIBO's computer vision, remote sensing and analytics. Ingredion reports 97% of Tier 1 priority crops responsibly sourced and targets 100% Tier 1 and 2 by 2030. CIBO said this is its fourth strategic partnership in 2026 and will supply program and storage reporting data to support compliance and consistent sustainability measurement.
Ingredion (NYSE: INGR) announced the immediate retirement of director Gregory B. Kenny after more than 21 years of service and named Siobhán Talbot to the board effective April 1, 2026.
Talbot brings 31 years at Glanbia, CEO and CFO experience, board service at CRH plc, and a track record of nearly doubling revenue during her tenure.